Polygon Management »

Maplight Therapeutics shares owned by Polygon Management

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Polygon Management from 13F filings

Historical chart of Polygon Management investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Polygon Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Polygon Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.9M 165k 17.57

More positions owned by Polygon Management

Uipath Cl A (PATH)
Kolibri Global Energy Com New (KGEI)
Lyft Cl A Com (LYFT)
Autolus Therapeutics Spon Ads (AUTL)
Sprinklr Cl A (CXM)
Workiva Com Cl A (WK)
Annexon (ANNX)
Praxis Precision Medicines I Com New (PRAX)
Celldex Therapeutics Com New (CLDX)
Arrowhead Pharmaceuticals (ARWR)
Pharvaris N V (PHVS)
Axsome Therapeutics (AXSM)
Dyne Therapeutics (DYN)
Mbx Biosciences (MBX)
Rapt Therapeutics Com New (RAPT)

View all positions for Polygon Management

Top funds holding Maplight Therapeutics

Novo A/S
T. Rowe Price Investment Management
Goldman Sachs Group
Nan Fung Group Holdings
5AM Venture Management
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Geode Capital Management
Blue Owl Capital Holdings
State Street Corporation
Lazard Asset Management
Board of Trustees of The Leland Stanford Junior University
Freestone Grove Partners
Polygon Management
Bnp Paribas Investment Partners

View all funds holding Maplight Therapeutics